IRIS
FALASCA, KATIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.386
EU - Europa 3.798
AS - Asia 2.837
SA - Sud America 341
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 11.384
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.318
SG - Singapore 1.119
CN - Cina 954
IT - Italia 713
IE - Irlanda 674
SE - Svezia 516
UA - Ucraina 511
TR - Turchia 358
DE - Germania 351
GB - Regno Unito 318
BR - Brasile 312
FR - Francia 239
FI - Finlandia 182
IN - India 144
RU - Federazione Russa 114
KR - Corea 86
VN - Vietnam 62
HK - Hong Kong 43
AT - Austria 41
CA - Canada 41
NL - Olanda 28
BE - Belgio 18
CZ - Repubblica Ceca 17
RO - Romania 14
AR - Argentina 12
BD - Bangladesh 12
ES - Italia 12
MX - Messico 12
PL - Polonia 12
CH - Svizzera 9
EC - Ecuador 7
IQ - Iraq 7
LT - Lituania 6
PK - Pakistan 5
TW - Taiwan 5
ZA - Sudafrica 5
AZ - Azerbaigian 4
EU - Europa 4
HR - Croazia 4
IL - Israele 4
JP - Giappone 4
SA - Arabia Saudita 4
VE - Venezuela 4
BB - Barbados 3
BG - Bulgaria 3
CO - Colombia 3
EE - Estonia 3
KE - Kenya 3
PS - Palestinian Territory 3
AU - Australia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HU - Ungheria 2
ID - Indonesia 2
IR - Iran 2
JM - Giamaica 2
JO - Giordania 2
LV - Lettonia 2
MA - Marocco 2
NP - Nepal 2
PA - Panama 2
PH - Filippine 2
RS - Serbia 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CL - Cile 1
CY - Cipro 1
DZ - Algeria 1
EG - Egitto 1
GE - Georgia 1
GT - Guatemala 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
ME - Montenegro 1
MK - Macedonia 1
MM - Myanmar 1
MY - Malesia 1
NI - Nicaragua 1
PY - Paraguay 1
QA - Qatar 1
SN - Senegal 1
TH - Thailandia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.384
Salva come PNG Salva come JPEG
Città #
Singapore 809
Chandler 780
Jacksonville 696
Dublin 657
Princeton 318
Southend 244
Nanjing 215
Beijing 203
Izmir 195
Ashburn 193
The Dalles 166
Santa Clara 142
Altamura 141
Munich 126
Chieti 111
Dearborn 108
Wilmington 104
Cambridge 97
Ann Arbor 87
Tongling 82
Boardman 74
Nanchang 65
Los Angeles 60
Pescara 56
Helsinki 45
New York 43
Hong Kong 42
Nuremberg 37
Shenyang 37
Rome 35
Pune 32
Seattle 31
Dong Ket 30
São Paulo 28
Tianjin 28
Turku 28
Washington 28
Hebei 27
Hefei 25
Jiaxing 25
Kunming 24
Woodbridge 24
Dallas 23
Milan 21
Brooklyn 20
Changsha 20
Hangzhou 20
Brussels 17
Toronto 17
Grevenbroich 16
Norwalk 16
Frankfurt am Main 15
San Francisco 15
Jinan 14
Changchun 13
Espoo 13
Augusta 12
Chicago 12
Moscow 12
Vienna 12
Brno 11
London 11
Rio de Janeiro 11
Warsaw 10
Boston 9
Falls Church 9
Montreal 9
Atlanta 8
Guangzhou 8
Lanzhou 8
Lappeenranta 8
Orange 8
San Mateo 8
San Vito Chietino 8
Tappahannock 8
Curitiba 7
Hanoi 7
Ho Chi Minh City 7
Mexico City 7
Ningbo 7
Salvador 7
Brasília 6
Chennai 6
Edinburgh 6
Houston 6
Lille 6
Porto Alegre 6
Ascoli Piceno 5
Bari 5
Denver 5
Düsseldorf 5
Olomouc 5
Phoenix 5
Shanghai 5
Taipei 5
Albenga 4
Andover 4
Ankara 4
Aparecida de Goiânia 4
Aquila 4
Totale 6.858
Salva come PNG Salva come JPEG
Nome #
Effect of probiotic supplement on cytokine levels in HIV-infected individuals: A preliminary study 131
Study of immune alterations in patients with Chronic Fatigue Sindrome with different etiologies 130
Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients. 123
Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C-virus infection and non-alcoholic fatty liver disease. 117
Metabolic modifications in HIV-infected women 116
Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. 112
Cytomegalovirus infection in heart-transplants recipients, in a central region of Italy 112
Relevance of plant lectins in human cell biology and immunology 111
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 110
Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. 109
Cytokines, Hepatic Fibrosis, and Antiretroviral Therapy Role in Neurocognitive Disorders HIV Related 108
Dual nucleoside therapy for HIV infection: analysis of results and factors influencing viral response and long term efficacy 106
STUDIO CLINICO MULTICENTRICO PER LA VALUTAZIONE DELLA MICROALBUMINURIA NEI PAZIENTI CON INFEZIONE DA HIV 105
Acute urinary retention due to HSV-1: a case report 104
Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients 104
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 103
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 103
Could S-100b be a marker of the neurologic involvement in HIV-affected patients? 102
Air and surface measurements of SARS-CoV-2 inside a bus during normal operation 102
Inguinal lymphadenopathy due to Bartonella henselae 101
The impact of homocysteine, B12, and D vitamins levels on functional neurocognitive performance in HIV-positive subjects 101
Interleukin-4 and interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapy. 100
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting 98
Antihypertensive and metabolic effects of telmisartan in hypertensive HIV-positive patients 97
Canakinumab in a subgroup of patients with COVID-19 97
Treatment with silibyn- Vitamin E- Phospholipid complex in patients with Hepatitis C infection. 96
Long term effect of telmisartan in HIV-positive male patients with high blood pressure 96
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 96
Quality of life, depression and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy. 94
Cystatin C, adipokines and cardiovascular risk in HIV infected patients. 94
Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: The D:A:D study 94
IL-1beta induces alkaline phosphatase in human phagocytes 93
Long term effect of switching to darunavir/ritonavir in HIV infected patients previously on protease inhibitor therapy 93
Effetti del trattamento con vitamina e sulla sintomatologia muscoloscheletrica soggettiva ed oggettiva della sindrome da fatica cronica 92
Iron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation 90
Different strategies of 25OH vitamin D supplementation in HIV+ subjects. 90
Predictive factors and prevalence of microalbuminuria in HIV-infected patients: a cross-sectional analysis 90
Beneficaial effects of telmisaratan in HIV+ diabetic insulin-dependent patient 89
New Therapeutic Options in Mild Moderate COVID-19 Outpatients 88
Methicillin-resistant staphylococcus epidermidis (MRSE) endocarditis treated with linezolid 88
Is the rate of virological failure to cART continuing to decline in recent calendar years? 88
Normal breathing releases SARS-CoV-2 into the air 88
BNT162b2 mRNA vaccination leads to long-term protection from COVID-19 disease 88
Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response. 87
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 87
Proteinuria in an African HIV-infected patient: effects of telmisartan. 86
Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy. 86
Cardiac Toxicity Associated with HCV Direct Antiviral Agents 86
High dose of erythropoietin in management of interferon/ribavirin induced anemia 84
Antiretroviral therapy management and rationalisation of available resources 84
Increased production of oncostatin-M by lymphomononuclear cells from HIV-1-infected patients with neuroAIDS. 83
The proinflammatory interleukin-21 elicits anti-tumor response and mediates autoimmunity 82
Periodontitis and cytokine patterns in HIV positive patients 82
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 82
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen 82
Short communication: Proangiogenic hematopoietic cells in acute HIV infection 80
Hypertension in HIV: Management and Treatment 80
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014 80
Atypical Sites of Lymphadenopathy after Anti-COVID-19 Vaccine: Ultrasound Features 80
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 79
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study 79
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 79
Severe HIV-associated hypertriglyceridemia treated with rosuvastatin plus mega-3 fatty acids 78
Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan. 78
Interleukin-31: a new cytokine involved in inflammation of the skin 77
Infected atrial mixoma: a rare cause of fever 77
Prevalence of anal, oral, penile and urethral Human Papillomavirus in HIV infected and HIV uninfected men who have sex with men 77
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 77
Use of quantitative ultrasound as bone mineral density evaluation in an Italian female population living with HIV: A real-life experience 77
Assessment of the Vanillin Anti-Inflammatory and Regenerative Potentials in Inflamed Primary Human Gingival Fibroblast 77
Effects of Probiotic Mixture Supplementation on the Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine in People Living with HIV 77
Effectiveness of first-generation HCV protease inhibitors: does HIV coinfection still play a role? 76
Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: The D: A: D study 76
Metabolic syndrome and cardiovascular risk in HIV-infected patients with lipodystrophy. 75
Ruolo delle citochine nella patogenesi delle malattie infettive 75
Switch to rilpivirine improves diabetes in an elderly HIV-positive patient 75
IL-15 an immunoregulatory and anti-cancer cytokine. Recent advances 74
Use of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV hepatitis. 74
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 74
Efficacy of canakinumab in mild or severe COVID-19 pneumonia 74
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. 73
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 73
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study 73
Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort study. 71
Esophagitis and anticonvulsant hypersensitivity syndrome. 71
Inflammatory cytokines and S-100b protein in patients with hepatitis C infection and cryoglobulinemias 70
Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count. 70
Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment. 70
Correlation between neurocognitive disorders and pattern cytokines in HIV+ patients 70
Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: A prospective international cohort study 70
Probiotics and anti-inflammatory processes in HIV infection: from Benchside Research to Bedside 70
Induction with ribavirin in a relapsing patient with chronic HCV hepatitis. 69
HIV-RNA decay in paired blood and semen samples of subjects receiving their first dolutegravir-based ART regimen 69
Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort. 67
Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome 67
Pidotimod and Immunological Activation in Individuals Infected with HIV 67
Predictive Value of Echocardiographic Pulmonary to Left Atrial Ratio for In-Hospital Death in Patients with COVID-19 66
Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008. 66
Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy. 66
Associations between immune depression and cardiovascular events in HIV infection. 66
Totale 8.669
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.204
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021737 0 6 153 18 73 170 33 24 57 82 52 69
2021/2022773 27 24 11 157 46 17 30 57 57 28 80 239
2022/20232.316 208 360 139 241 205 439 131 174 252 27 67 73
2023/20241.157 76 50 84 42 100 326 262 58 9 19 12 119
2024/20252.970 187 528 383 112 60 134 97 183 267 209 336 474
2025/2026565 470 95 0 0 0 0 0 0 0 0 0 0
Totale 12.171